Agoracom: Small Cap Investment - Pluristem Life Systems, Inc. - Re: Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Back To Forum List View

Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten

greybeard

Apr 17, 2012 09:37AM

Re: Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten

bankerson

Apr 17, 2012 09:46AM

greybeard

Rank: Mail Room [?]

Points: 221 [?]

Votes: 3 Score: 4.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten

in response to

Re: Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten

bankerson

posted on Apr 19, 2012 09:24PM

What I really want to post some day is FDA approval of various therapies, and contracts to provide PSTI cells to other companies. For Billions of dollars, of course.

1 Recommendations

Re: Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermitten